Dr. Öğr. Üyesi AHMED SERKAN EMEKLİ

Yayın Ağı

Makaleler 31

1. Association of somatosensory evoked potentials with cervical spinal cord atrophy and disability progression in multiple sclerosis

Toksoy C. K., Ayaz T. B., Emekli A. S., GÜNDÜZ T., KÜRTÜNCÜ M.

Multiple Sclerosis and Related Disorders , cilt.112, 2026 (SCI-Expanded, Scopus)

2. Impact of Intravenous Immunoglobulin on Neuroinflammation Markers in Patients With Electrical Status Epilepticus During Slow Sleep.

Koral G., Tuzun E., Emekli A. S., Dortkol S. O., Savas M., Oz F., et al.

In vivo (Athens, Greece) , cilt.40, sa.4, ss.2014-2024, 2026 (SCI-Expanded, Scopus)

3. Effect of immunotherapy on seizure severity and spike-wave index in epileptic encephalopathy with spike-wave activation in sleep: The value of EEG spikes in monitoring treatment response

Topaloğlu P., Dörtkol O., Emekli A. S., Elmalı Yazıcı A. D., Tüzün E., Yılmaz V., et al.

Epilepsy Research , cilt.226, ss.107861, 2026 (Hakemli Dergi)

4. Early determinants of long-term outcomes in multiple sclerosis

Dörtkol O., Emekli A. S., Hacılar E., Öztürk Erden S., GÜNDÜZ T., KÜRTÜNCÜ M.

MULTIPLE SCLEROSIS AND RELATED DISORDERS , cilt.107, 2026 (SCI-Expanded, Scopus)

5. Long-term prognostic features of pediatric-onset multiple sclerosis: A large cohort from Türkiye.

Duman İlki C., Emekli A. S., GÜNDÜZ T., KÜRTÜNCÜ M., Eraksoy M.

Multiple sclerosis and related disorders , cilt.107, ss.107013, 2026 (SCI-Expanded, Scopus)

6. Cerebral tumefactive demyelinating lesions: clinical spectrum, long-term outcomes, and treatment

Kizek Ö., Emekli A. S., GÜNDÜZ T., KÜRTÜNCÜ M., Eraksoy M.

Acta Neurologica Belgica , cilt.126, sa.1, ss.109-121, 2026 (SCI-Expanded, Scopus)

7. Corpus callosum citotoxikus laesiója thrombosis sinus venosi cerebri következtében Cytotoxic lesion of corpus callosum associated with cerebral venous sinus thrombosis

Emekli I., Emekli A. S.

Ideggyogyaszati szemle , cilt.79, sa.1-2, ss.69-72, 2026 (SCI-Expanded, Scopus)

8. Neurofilament Light Chain as a Potential Serum-Based Biomarker for Monitoring Disease Activity in Neuro-Behcet's Disease

Tezel M., KARPUZOĞLU F. H., Toz H. T., EMEKLİ A. S., DİLSİZ E., GÜNDÜZ T., et al.

NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY , cilt.63, ss.479-481, 2026 (SCI-Expanded, Scopus, TRDizin)

9. Comorbid autoimmune diseases do not influence long-term disability progression in multiple sclerosis

Emekli A. S., GÜNDÜZ T., KÜRTÜNCÜ M.

Acta Neurologica Belgica , 2026 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

10. Clinical Use of Interleukin-6 Blockade in Neuroimmunological Disorders

Erdal M., Ari A., Emekli A. S., Çarçak Yılmaz N., Kurtuncu M.

NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY , cilt.63, ss.482-494, 2026 (SCI-Expanded, Scopus, TRDizin)

11. Challenging The Diagnosis of Multiple Sclerosis: Histopathological Insights Gained Through Brain Biopsies.

Taşkıran E., Öztürk B., Ata N., Birinci Ş., Emekli A. S., Kürtüncü M.

Noro psikiyatri arsivi , cilt.63, ss.277-281, 2025 (SCI-Expanded, Scopus, TRDizin)

12. The Impact of Wearable Technology on Median Nerve Conduction Studies: A Comparative Analysis of Smartwatch and Traditional Watch Wearers

EMEKLİ A. S., APAYDIN A. S.

Medical records-international medical journal (Online) , cilt.7, sa.3, ss.547-553, 2025 (TRDizin)

13. Comparative analysis of five-year clinical outcomes of autologous hematopoietic stem cell transplantation and alemtuzumab in multiple sclerosis patients.

Manazoğlu H. C., İşkan G., Gündüz T., Emekli A. S., Akman G., Altunrende B., et al.

Multiple sclerosis and related disorders , cilt.100, ss.106542, 2025 (SCI-Expanded, Scopus)

14. Clinical characteristics and prognostic clinical factors of anti-gamma-aminobutyric acid-B receptor (GABAB-R) encephalitis in Türkiye: a multicenter study

Gozubatik-Celik R. G., Baykan B., Emekli A. S., Tuzun E., Soysal A., Uzunkopru C., et al.

NEUROLOGICAL RESEARCH , cilt.47, sa.7, ss.612-625, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

15. Clinical and Laboratory Characteristics of Patients with Neurosarcoidosis Nörosarkoidozlu Hastaların Klinik ve Laboratuvar Özellikleri

Emekli A. S., Gündüz T., Samanci B., Kürtüncü M.

Noropsikiyatri Arsivi , cilt.62, sa.2, ss.156-163, 2025 (SCI-Expanded, Scopus, TRDizin)

16. Anti-JCV antibody index seroconversion in Turkish multiple sclerosis patients treated with natalizumab

Şahin E., GÜNDÜZ T., Emekli A. S., Ercanoğlu M., Erden S. Ö., KÜRTÜNCÜ M.

NEUROLOGICAL SCIENCES , cilt.46, sa.4, ss.1799-1805, 2025 (SCI-Expanded) Sürdürülebilir Kalkınma

17. Effects of immune modulatory treatment on language and psychiatric profile in patients with electrical status epilepticus in sleep (ESES)

Emekli A. S., Dörtkol Ş. O., Savaş M., Öz F., İşcen P., Topaloğlu P., et al.

EPILEPSY & BEHAVIOR , cilt.163, 2025 (SCI-Expanded, Scopus)

18. Idiopathic intracranial hypertension without papilledema maybe underdiagnosed

Emekli A. S., Hines D. A., Miller N. J., Schulte A., Kaufman D.

Neurological Sciences , cilt.45, sa.10, ss.5077-5081, 2024 (SCI-Expanded, Scopus)

19. Pseudotumor Cerebri Due to a Rare Cause of Primary Hypoparathyroidism: Barakat Syndrome.

Emekli A. S., Shmunes M., Goodfellow G., Proctor E., Al-Abdulghani A., Kaufman D.

Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society , 2024 (SCI-Expanded, Scopus)

20. Serum IgG of patients with relapsing inflammatory optic neuropathy immunoreacts with Sox2-positive glial cells of the optic nerve

Erdağ E., Emekli A. S., Gündüz T., Küçükali C. İ., Kürtüncü M., Tüzün E.

MULTIPLE SCLEROSIS AND RELATED DISORDERS , cilt.73, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

21. Lesion probability map in cerebral vein thrombosis due to Behcet's disease

Emekli A. S., Dogan F. U., Gunduz T., Sezgin M., Ekizoglu E., Yesilot N., et al.

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES , cilt.26, sa.1, ss.145-150, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

22. Why electrophysiological reassessment is needed? The experience of our laboratory - A cross-sectional study

Gencdal I., ÖZDAĞ ACARLI A. N., ELMALI YAZICI A. D., Emekli A. S., Oege A. E., BASLO M. B., et al.

NEUROLOGICAL SCIENCES AND NEUROPHYSIOLOGY , cilt.39, sa.2, ss.74-78, 2022 (SCI-Expanded, TRDizin)

23. Lesion Distribution Pattern of Parenchymal Neuro-Behcet's Disease Using Probability Mapping

Emekli A. S., Ersozlu E., Emekli M. A., Gunduz T., Kurtuncu M.

MULTIPLE SCLEROSIS AND RELATED DISORDERS , 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

24. Olfactory dysfunction in patients with cluster headache

Samancı B., Şahin E., Şen C., Samancı Y., Sezgin M., Emekli S., et al.

EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY , sa.11, ss.4361-4365, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

25. Anti-GAD associated post-infectious cerebellitis after COVID-19 infection

Emekli A. S., Parlak A., Gocen N. Y., Kurtuncu M.

NEUROLOGICAL SCIENCES , sa.10, ss.3995-4002, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

26. Dopamine Agonist-Associated Hiccup in Parkinson's Disease: A Case Report

Emekli A. S., HANAĞASI H. A.

NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY , cilt.58, sa.3, ss.253-254, 2021 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma

27. A novel PNPLA6 mutation in a Turkish family with intractable Holmes tremor and spastic ataxia

Emekli A. S., Samanci B., Simsir G., Hanagasi H. A., Gurvit H., Bilgic B., et al.

NEUROLOGICAL SCIENCES , sa.4, ss.1535-1539, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

28. The clinical significance and electrophysiologic findings of fixation-off and closure of the eyes sensitivity: Data from a prospective unselected population

Dede H. Ö., Bebek N., Emekli S., Baykan B., Yapıcı Z., Gökyiğit A.

Epilepsy Research , cilt.170, 2021 (SCI-Expanded, Scopus)

29. Diffuse enlargement of cerebral vasculature in an adult patient operated for cyanotic congenital heart disease

Emekli A. S., Ekizoglu E., Yesilot N.

CARDIOLOGY IN THE YOUNG , sa.5, ss.734-736, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

30. Amiselimod: A New Oral Agent in the Treatment of Multiple Sclerosis

Emekli A. S.

TURKISH JOURNAL OF NEUROLOGY , sa.3, ss.148-149, 2017 (ESCI, Scopus, TRDizin) Sürdürülebilir Kalkınma

31. Double-Organ Bias in Published Randomized Controlled Trials of Glaucoma

Esen F., Kostek M., Emekli A. S., ERASLAN M.

JOURNAL OF GLAUCOMA , sa.6, ss.520-522, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 16

1. MEDICATION ADHERENCE IN MULTIPLE SCLEROSIS: IMPACT OF DISEASE SUBTYPE AND TREATMENT LINE IN A TERTIARY CARE SETTING

Erdal M., Açıkgöz B., Arı A., Emekli A. S., Koçak E. G., Kurt İ., et al.

ESCP symposium on clinical pharmacy. From interprofessional education to interprofessional practice, Grenoble, Fransa, 26 - 28 Kasım 2025, ss.98, (Özet Bildiri)

2. Nöro-Behçet Hastalığında Çoklu Nörolojik Tutulum Paternleri: Klinik Özellikler ve Hastalık Seyri

Ateş D., Emekli A. S., Gündüz T., Akman G., Kürtüncü M.

61. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 13 - 17 Aralık 2025, ss.138, (Özet Bildiri)

3. EDSS Progression and Upper Extremity Disability Worsening in Multiple Sclerosis: Nine-Hole Peg Test Dynamics Across EDSS Strata

GÜNDÜZ T., EMEKLİ A. S., Tezel M., KÜRTÜNCÜ M.

41st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona, İspanya, 24 - 26 Eylül 2025, cilt.31, ss.210-211, (Özet Bildiri)

4. Distribution of Cerebral Lesions in Neuromyelitis Optica Spectrum Disorder and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease

Manazoglu H., Ayaz T. B., EMEKLİ A. S., GÜNDÜZ T., KÜRTÜNCÜ M.

41st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona, İspanya, 24 - 26 Eylül 2025, cilt.31, ss.784, (Özet Bildiri)

5. Distribution of Cerebral Lesions in Primary Central Nervous System Vasculitis

Ayaz T. B., EMEKLİ A. S., GÜNDÜZ T., Manazoglu H., Koc E. R., Kotan D., et al.

41st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona, İspanya, 24 - 26 Eylül 2025, cilt.31, ss.1045, (Özet Bildiri)

6. Forme Fruste Nöro-Behçet Hastalarının Uzun Dönem Takip Sonuçları

Ateş D., Emekli A. S., Gündüz T., Kürtüncü M., Akman G.

12. Nöroimmünoloji Okulu, Girne, Kıbrıs (Kktc), 8 - 11 Mayıs 2025, ss.27, (Özet Bildiri)

7. Clinical and Radiological Features of Anti-MOG Associated Cerebral Cortical Encephalitis

Manazoglu H. C., Dogan I. G., Demir S., KILIÇ A., Ozakbas S., SARIDAŞ F., et al.

Annual Meeting of the American-Academy-of-Neurology (AAN), California, Amerika Birleşik Devletleri, 5 - 09 Nisan 2025, cilt.104, (Özet Bildiri)

8. Epstein-Barr Virüsü İlişkili Bir Transvers Miyelit Olgusu: Olgu Sunumu

Ateş D., Emekli A. S., Gündüz T., Kürtüncü M.

60. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 27 Kasım - 02 Aralık 2024, ss.280, (Özet Bildiri)

9. İVİG Tedavisinin Uykuda Elektriksel Status Epileptikus Hastalarındaki İmmün Cevap ile İlişkisi.

Koral G., Soylu S., Topaloğlu P., Emekli A. S., Karaaslan Z., Yüceer Korkmaz H., et al.

13. Klinik Nöroimmünoloji Sempozyumu, Antalya, Türkiye, 13 - 18 Mayıs 2024, (Yayınlanmadı)

10. Alternate-Day Fingolimod Tapering: Impact on Rebound Disease Activity in Patients with Multiple Sclerosis

Gündüz T., İşkan N. G., Sevimli A., Büke B., Emekli A. S., Kürtüncü M.

The 40th Congress of the European Committee for Treatment and Research in Multiple Sclerosis, Kobenhavn, Danimarka, 18 Eylül 2024, cilt.30, ss.4-124, (Özet Bildiri)

11. Alternate-Day Fingolimod Tapering: Impact on Rebound Disease Activity in Patients with Multiple Sclerosis

GÜNDÜZ T., İŞKAN N. G., Sevimli A., BÜKE B., Emekli A. S., KÜRTÜNCÜ M.

40th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Copenhagen, Danimarka, 18 - 20 Eylül 2024, ss.107, (Özet Bildiri)

12. Comparative Analysis of Five-Year Clinical Outcomes of Autologous Hematopoietic Stem Cell Transplantation and Alemtuzumab in Multiple Sclerosis Patients

Manazoglu H. C., Iskan G., GÜNDÜZ T., EMEKLİ A. S., Demir G. A., Altunrende B., et al.

40th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Copenhagen, Danimarka, 18 - 20 Eylül 2024, cilt.30, ss.1183, (Özet Bildiri)